Form4insider filings, from the source

SEC Form 4 · accession 0001209191-19-015828

Athenex, Inc. · ATNX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Rudolf Kwan
Officer — EVP, Chief Medical Officer
Period of report
Feb 28, 2019
Accepted (ET)
Mar 4, 2019 · 5:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001300699

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stockholding———98,224D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F10$13.17Feb 28, 2019A120,000A—Feb 28, 2029Common Stock120,000120,000D
Stock Option (Right to Buy)F1$4.55holding————Dec 10, 2019Common Stock24,00024,000D
Stock Option (Right to Buy)F2$4.55holding————May 9, 2021Common Stock48,00048,000D
Stock Option (Right to Buy)F3$4.55holding————Jan 2, 2023Common Stock96,00096,000D
Stock Option (Right to Buy)F4$4.55holding————May 13, 2023Common Stock48,00048,000D
Stock Option (Right to Buy)F5$4.55holding————Feb 12, 2024Common Stock120,000120,000D
Stock Option (Right to Buy)F6$4.55holding————Jun 12, 2024Common Stock48,00048,000D
Stock Option (Right to Buy)F7$5.50holding————Dec 16, 2024Common Stock200,000200,000D
Stock Option (Right to Buy)F8$7.50holding————May 22, 2025Common Stock120,000120,000D
Stock Option (Right to Buy)F9$11.00holding————Jun 13, 2027Common Stock140,000140,000D

Explanation of responses